“Signalling pathways in cancer” — a report from the European Society for Medical Oncology symposium

Abstract

On 4–5 March, 2016 the next symposium of the European Society for Medical Oncology (ESMO) about “Signalling pathways in cancer” was held in Sitges, Spain. The topics of the lectures were focused this year on mechanisms of action, resistance, new drugs, and the development of new therapies targeting human epidermal growth factor (HER) family receptors. During two days of symposium participants had an opportunity to familiarise themselves with the results of current research relevant to the main topic. This summary discusses selected topics presented during the symposium.